respiratory
COPD

Promise in targeting parasympathetic nerve in COPD


Targeted lung denervation won’t replace drug therapy but instead has the potential to complement drug therapy for patients with moderate to severe COPD. Dr Dirk-Jan Slebos, from the University Medical Centre Groningen, Netherlands, presented the findings of AIRFLOW 2 – a phase 2 randomised controlled study of targeted lung denervation plus tiotropium versus sham bronchoscopy ...

Already a member?

Enter your email to keep reading.


OR